Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

‘Mein Kampf’ Hitler dan teknik kambing hitam dalam narasi antek asing

● Label “antek asing” yang digunakan Presiden Prabowo adalah bentuk teknik ‘othering’ atau mengambinghitamkan kelompok tertentu.● Pola ini serupa dengan teknik prop...

Pemilihan Adies Kadir dan risiko keruntuhan independensi MK

Gedung Mahkamah Konstitusi di Jakarta.duy 86/Shutterstock● Pemilihan Adies Kadir sebagai Hakim MK mencerminkan upaya politisasi dan sinyal perusakan independensi MK.● Penujukkan Adies lega...

Beban utang Indonesia dan negara berkembang lainnya meningkat tahun ini. Bagaimana mitigasinya?

● Utang negara-negara berkembang dunia, termasuk Indonesia, berisiko meningkat tahun ini.● Anggaran Indonesia terbebani biaya bunga utang yang nilainya terus melambung.● Pemerintah p...